Cancer Family
Malignant Respiratory System Neoplasm
CI-CAN-00000249Explore in graph →
2,650 active trials51 approved drugs619 evidence items
- NCIt
- C4571
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000249Explore in graph →
Clinical trials
11,128 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,492)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02076282 | MRI Optimization Study in Stage III NSCLC | unknown | — | 30 | UMC UtrechtOTHER | 1 | Feb 3, 2015 | clinicaltrials |
| NCT02350361 | Endostar Combination With Chemotherapy and EGFR-TKI in Lung Cancer Rechallenging Treatment After Acquired Resistance. | unknown | Phase 2 / Phase 3 | 60 | Peking University Third HospitalOTHER | 1 | Jan 29, 2015 | clinicaltrials |
| NCT01337037 |
| Modified Video-assisted Thoracoscopic Surgery (VATS) Lobectomy for Early-stage Non-small Cell Lung Cancer (NSCLC) |
| unknown |
| — |
| 1,000 |
| Peking University People's HospitalOTHER |
| 1 |
| Jan 27, 2015 |
| clinicaltrials |
| NCT01707888 | VATS Major Lung Resection for Chinese Early-stage Non-small Cell Lung Cancer | unknown | — | 500 | Peking University People's HospitalOTHER | 1 | Jan 27, 2015 | clinicaltrials |
| NCT02338011 | Comparator-Controlled Study for EGFR(+) Patients With Multiple BMs From NSCLC (BROKE) (EGFR-epidermal Growth Factor Receptor;BM-brain Metastases)(EGFR) | unknown | Phase 2 / Phase 3 | 210 | Shanghai Chest HospitalOTHER | 1 | Jan 26, 2015 | clinicaltrials |
| NCT01690390 | Dose Escalation of Icotinib in Advanced Non-small Cell Lung Carcinoma (NSCLC) Patients Evaluated as Stable Disease | unknown | Phase 2 | 180 | Betta Pharmaceuticals Co., Ltd.INDUSTRY | 1 | Dec 30, 2014 | clinicaltrials |
| NCT02324530 | Evaluation of Continuous Positive Airway Pressure for Tumor Motion Management in Radiotherapy | unknown | Phase 2 | 30 | Sheba Medical CenterOTHER_GOV | 1 | Dec 24, 2014 | clinicaltrials |
| NCT01763385 | Erlotinib With Concurrent Brain Radiotherapy and Secondary Brain Radiotherapy After Recurrence With Erlotinib in NSCLC Non-increased-intracranial-pressure Symptomatic Brain Metastases(TRACTS) | unknown | Phase 2 | 210 | Wu Jieping Medical FoundationOTHER | 1 | Dec 23, 2014 | clinicaltrials |
| NCT02185495 | Screening for Early Lung Cancer in Shanghai, China | unknown | Phase 2 | 3,000 | Shanghai Changzheng HospitalOTHER | 1 | Dec 18, 2014 | clinicaltrials |
| NCT02319577 | GEfitinib Plus viNOrelbine in Advanced EGFR Mutated NSCLC. GENOA Trial | unknown | Phase 2 | 80 | IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, ItalyOTHER | 1 | Dec 18, 2014 | clinicaltrials |
| NCT01920789 | Stereotactic Precision And Conventional Radiotherapy Evaluation(SPACE) | unknown | N/A | 102 | Ass. Prof. Jan NymanNETWORK | 0 | Dec 9, 2014 | clinicaltrials |
| NCT01877902 | Study Of Use Of Pemetrexed In Patients With Non-Small Lung Cancer Metastatic In Andalusian Public Health System | unknown | — | 190 | Fundación Pública Andaluza Progreso y SaludOTHER | 1 | Dec 5, 2014 | clinicaltrials |
| NCT01784549 | Customized Neoadjuvant Versus Standard Chemotherapy in NSCL Patients With Resectable Stage IIIA (N2)Disease(CONTEST) | unknown | Phase 2 | 168 | IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, ItalyOTHER | 1 | Nov 25, 2014 | clinicaltrials |
| NCT02288026 | Comparison of Different Types of Surgery in Treating Patients With Early-stage Non-small Cell Lung Cancer | unknown | — | 630 | Capital Medical UniversityOTHER | 1 | Nov 11, 2014 | clinicaltrials |
| NCT02285660 | Evaluation of 4D-contrast Enhanced PET-CT in Tumour Volume Definition | unknown | N/A | — | The Leeds Teaching Hospitals NHS TrustOTHER | 1 | Nov 7, 2014 | clinicaltrials |
| NCT02283476 | The Comparative Study on Rh-Endostatin (Endostar®) Continuous Intravenous Infusion and Routine i.v in Combination With GP Regimens for Phase III B/IV Squamous Cell Lung Cancer and Biological Markers Exploration. | unknown | Phase 3 | 200 | Jiangsu Simcere Pharmaceutical Co., Ltd.INDUSTRY | 1 | Nov 6, 2014 | clinicaltrials |
| NCT02281708 | Multicenter Randomized Controlled Trial Adjuvant Chemotherapy vs Observation in pStage Ib Lung Adenocarcinoma | unknown | Phase 3 | 1,012 | Seoul National University HospitalOTHER | 1 | Nov 3, 2014 | clinicaltrials |
| NCT02272127 | Study of Chemotherapy Plus Icotinib to Treat EGFR Mutation-positive Non-small-cell Lung Cancer | unknown | Phase 2 | 100 | Nanfang Hospital, Southern Medical UniversityOTHER | 1 | Oct 22, 2014 | clinicaltrials |
| NCT02262897 | The Efficacy and Safety of Nab-paclitaxel in Pretreated Patients With Extensive Disease of Small Cell Lung Cancer | unknown | Phase 2 | 40 | Tongji UniversityOTHER | 1 | Oct 13, 2014 | clinicaltrials |
| NCT01426841 | Pilot Project of Adaptive Thoracic Radiotherapy for Small Cell Lung Cancer | unknown | Phase 1 | 10 | AHS Cancer Control AlbertaOTHER | 1 | Oct 2, 2014 | clinicaltrials |
| NCT01624051 | A Study Comparing Chemotherapy Dosing Based on Either Standard Body Surface Area or Lean Body Mass in Patients With Advanced Lung Cancer | unknown | Phase 2 | 144 | AHS Cancer Control AlbertaOTHER | 1 | Sep 30, 2014 | clinicaltrials |
| NCT01424709 | Individualized Chemotherapy Based on BRCA1 and RRM1 mRNA for Advanced Non-small Cell Lung Cancer (NSCLC)(BRAVO) | unknown | Phase 2 | 120 | Tongji UniversityOTHER | 1 | Sep 25, 2014 | clinicaltrials |
| NCT02247713 | An International Study on the Use of PET/CT in Radiotherapy Planning in Low and Middle Income Countries(PERTAIN) | unknown | — | 520 | The Netherlands Cancer InstituteOTHER | 0 | Sep 25, 2014 | clinicaltrials |
| NCT02239432 | Telomere Biology in Early Adenocarcinoma of the Lung | unknown | — | 100 | Meir Medical CenterOTHER | 1 | Sep 12, 2014 | clinicaltrials |
| NCT02224547 | Risk-adapted Stereotactic Body Radiotherapy for Early Non-Small Cell Lung Cancer Using the VERO Stereotactic Body Radio Therapy System | unknown | Phase 2 | 58 | Universitair Ziekenhuis BrusselOTHER | 1 | Sep 9, 2014 | clinicaltrials |
| NCT02215356 | Icotinib With Concurrent Radiotherapy Versus Chemotherapy With Concurrent Radiotherapy in Non-small Cell Lung Cancer | unknown | Phase 2 | 120 | Betta Pharmaceuticals Co., Ltd.INDUSTRY | 1 | Aug 13, 2014 | clinicaltrials |
| NCT02191059 | Phase II Clinical Study of Intermittent High Dose of Icotinib in Combination With Docetaxel to Treat Lung Cancer | unknown | Phase 2 | 60 | Shandong Cancer Hospital and InstituteOTHER | 1 | Jul 31, 2014 | clinicaltrials |
| NCT02002117 | Genotyping of Non-small Cell Lung Cancer | unknown | — | 100 | National Taiwan University HospitalOTHER | 1 | Jul 30, 2014 | clinicaltrials |
| NCT02202655 | Study of Changes of Lymphocyte Subsets in Chemotherapy Course of Patients With Non-small Cell Lung Cancer(NSCLC) | unknown | — | 50 | Beijing Chao Yang HospitalOTHER | 1 | Jul 29, 2014 | clinicaltrials |
| NCT01786122 | Clinical Trial: Effectiveness and Efficiency of Physical Exercise in Cancer Patients(EFICANCER) | unknown | N/A | 250 | Basque Health ServiceOTHER_GOV | 1 | Jul 23, 2014 | clinicaltrials |
| NCT02195076 | Non Invasive Detection of Lung and Breast Cancer by Odor Signature | unknown | — | 400 | BioSense Medical LTDINDUSTRY | 1 | Jul 21, 2014 | clinicaltrials |
| NCT02195336 | dMR During First Line Treatment of Non Squamous Lung Cancer: Time Course and Prognostic and Predictive Impact.(BevMar) | unknown | N/A | 20 | Karl KölbeckOTHER | 1 | Jul 21, 2014 | clinicaltrials |
| NCT02195453 | Chemotherapy Combined With Yangzhengxiaoji Capsule in Patients With Advanced Non-Small Cell Lung Cancer | unknown | Phase 4 | 520 | Shandong Cancer Hospital and InstituteOTHER | 0 | Jul 21, 2014 | clinicaltrials |
| NCT02121379 | Randomized Clinical Trial of 8 Weeks Pulmonary Rehabilitation in Advanced Stage Lung Cancer Patients With COPD During Cytotoxic Chemotherapy | unknown | N/A | 40 | Seoul National University HospitalOTHER | 1 | Jun 2, 2014 | clinicaltrials |
| NCT02146118 | A Phase II Study to Assess Efficacy of Combined Treatment With Erlotinib (Tarceva) and Silybin-phytosome (Siliphos) in Patients With EGFR Mutant Lung Adenocarcinoma | unknown | Phase 2 | 42 | MedicalLogicINDUSTRY | 1 | May 23, 2014 | clinicaltrials |
| NCT02139579 | Efficacy and Safety Study of Bevacizumab Plus Chemotherapy in EGFR-TKI Resistant Non-Squamous Non-Small Cell Lung Cancer | unknown | Phase 2 | 24 | Sun Yat-sen UniversityOTHER | 0 | May 15, 2014 | clinicaltrials |
| NCT01193829 | Development of Circulating Tumour Cell Molecular Diagnostics Using a Novel Microfluidic Device | unknown | — | 30 | National University Hospital, SingaporeOTHER | 1 | Apr 28, 2014 | clinicaltrials |
| NCT01969955 | Nab-paclitaxel as Second-line Therapy in Locally Advanced or Metastatic Squamous Lung Cancer | unknown | Phase 2 | 50 | Chinese Academy of Medical SciencesOTHER | 1 | Apr 25, 2014 | clinicaltrials |
| NCT02090166 | Lung Cancer Detection by Measuring Monocyte Activity(EDLC) | unknown | N/A | 950 | Carmel Medical CenterOTHER | 1 | Mar 18, 2014 | clinicaltrials |
| NCT02075957 | Identification by Microarrays of the Risks of Metastatic Relapse, Toxicity and Resistance to Adjuvant Chemotherapy in Completely Resected Non-small Cell Lung Cancer(SITRR) | unknown | — | 192 | University Hospital, AngersOTHER_GOV | 1 | Mar 3, 2014 | clinicaltrials |
| NCT01861223 | Afatinib Plus Nimotuzumb for NSCLC | unknown | Phase 1 / Phase 2 | 50 | Samsung Medical CenterOTHER | 1 | Feb 25, 2014 | clinicaltrials |
| NCT01852838 | The Contribution of Induced Glycolysis to the Exhaled Volatile Organic Compounds' (VOCs) Signature in Lung Cancer | unknown | — | 70 | Sheba Medical CenterOTHER_GOV | 1 | Feb 21, 2014 | clinicaltrials |
| NCT02066038 | Intermittent and Maintenance of Erlotinib in Combination With Pemetrexed/Carboplatin in Ⅲb/IV Non Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Mutation | unknown | Phase 2 | 60 | Sun Yat-sen UniversityOTHER | 0 | Feb 19, 2014 | clinicaltrials |
| NCT02058433 | Safety Study of Individual Paclitaxel Dose Adjustment Based on Pharmacokinetics in Non-Small Cell Lung Cancer (NSCLC) | unknown | Phase 3 | 140 | Caicun ZhouOTHER | 1 | Feb 10, 2014 | clinicaltrials |
| NCT01130571 | Establishment and Characterization of Patient-Derived Non-Small Cell Lung Cancer Xenografts and Cell Cultures | unknown | — | — | National University Hospital, SingaporeOTHER | 1 | Jan 22, 2014 | clinicaltrials |
| NCT02039518 | Study of Gemcitabine Maintenance Treatment in Patients With Extensive SCLC Patients | unknown | Phase 2 | 160 | Fudan UniversityOTHER | 1 | Jan 17, 2014 | clinicaltrials |
| NCT02036359 | Erlotinib Monotherapy Versus Docetaxel and Cisplatin as Neoadjuvant Therapy in Patients of stageIIIA Lung ca(Oncology) | unknown | Phase 2 | 76 | National Taiwan University HospitalOTHER | 1 | Jan 15, 2014 | clinicaltrials |
| NCT00717353 | Genetic Polymorphisms in UGT1A6 and UGT2B7 in Asian Population: Association With Lung Cancer Phenotype | unknown | — | — | National University Hospital, SingaporeOTHER | 1 | Jan 14, 2014 | clinicaltrials |
| NCT00958555 | A Study of Predictive and Prognostic Markers in Patients With Non-small Cell Lung Cancer | unknown | — | — | National University Hospital, SingaporeOTHER | 1 | Jan 14, 2014 | clinicaltrials |
| NCT01784185 | Virtual Bronchoscopy (VB) vs. Endobronchial Ultrasound (EBUS) Guided Mediastinal Sampling(VB/EBUS-TBNA) | unknown | N/A | 60 | Medical University of WarsawOTHER | 1 | Jan 13, 2014 | clinicaltrials |
Data updated 23 days agoSource updated Feb 3, 2015source: clinicaltrials